ArticleJournal of inflammation research2025
Glyuranolide-Dependent Inhibition of NF-κB/Akt Pathways by Sini Decoction Enhances Caspase-3-Mediated Apoptosis in Colorectal Cancer.
Article in Journal of inflammation research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Colorectal carcinoma (CRC) is a leading cause of gastrointestinal malignancy worldwide. Its development is closely linked to aberrant activation of NF-κB and Akt signaling pathways. This study aimed to evaluate the inhibitory effects of Compound Sini Decoction (SND), a traditional Chinese medicine, on CRC and clarify its molecular mechanisms. Methods: An AOM/DSS-induced mouse CRC model was used to assess the in vivo effects of SND. Network pharmacology identified potential targets, while molecular docking and kinetic simulations evaluated binding interactions. In vitro, SND-containing mouse serum was applied to HCT116 and SW480 cells to examine proliferation, migration, apoptosis, ROS production, and signaling pathway modulation. Results: SND significantly reduced tumor burden, alleviated symptoms, and decreased body weight loss in mice. Network analysis highlighted NFKB1, CASP3, and AKT1 as key targets, suggesting regulation of NF-κB, Caspase-3, and Akt pathways. In vitro, SND inhibited cell proliferation and migration, induced apoptosis, promoted ROS accumulation, suppressed NF-κB and AKT1 phosphorylation, and enhanced CASP3 cleavage. Molecular docking showed Glyuranolide had the strongest binding affinity, particularly with NFKB1 and AKT1, indicating it as a likely effector compound. Conclusion: SND exerts anti-CRC effects through multi-target synergistic mechanisms involving NF-κB/Akt signaling and Caspase-3-mediated apoptosis. Glyuranolide may represent its key active molecule. These findings provide preliminary evidence supporting SND or its derivatives as potential candidates for precision CRC therapy and suggest a strategy to overcome resistance to single-target treatment. Further studies are warranted to confirm the clinical translational value of SND and the specific role of Glyuranolide.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.